norcantharidin has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Z; Li, H; Li, J; Mo, L; Su, B; Xu, L; Zhao, C; Zhao, Z | 1 |
| Chung, JG; Huang, YP; Ko, FY; Lin, CC; Lin, JP; Yang, JS; Yu, CC; Yu, CS | 1 |
2 other study(ies) available for norcantharidin and Bladder Cancer
| Article | Year |
|---|---|
Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through Promoting Autophagy in Acidic Culture.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Immunogenic Cell Death; Mice; Tumor Microenvironment; Urinary Bladder Neoplasms | 2022 |
Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Bridged Bicyclo Compounds, Heterocyclic; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA Damage; Fas Ligand Protein; fas Receptor; Humans; Medicine, Chinese Traditional; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Up-Regulation; Urinary Bladder Neoplasms | 2012 |